Live Breaking News & Updates on Inovio pharmaceuticals company profile

Stay informed with the latest breaking news from Inovio pharmaceuticals company profile on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Inovio pharmaceuticals company profile and stay connected to the pulse of your community

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Short Interest Up 10.8% in March

Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Get Free Report) was the target of a significant increase in short interest in March. As of March 15th, there was short interest totalling 2,060,000 shares, an increase of 10.8% from the February 29th total of 1,860,000 shares. Based on an average trading volume of 526,600 shares, the short-interest ratio […]

Canada , Metlife-investment-management , Inovio-pharmaceuticals , Charles-schwab-investment-management-inc , Nasdaq , Hsbc-holdings , Royal-bank , News-ratings-for-inovio-pharmaceuticals-daily , Vanguard-group-inc , Renaissance-technologies , Inovio-pharmaceuticals-inc

Inovio Pharmaceuticals (NASDAQ:INO) Upgraded to Hold by StockNews.com

Inovio Pharmaceuticals (NASDAQ:INO) Upgraded to Hold by StockNews.com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Canada , Inovio-pharmaceuticals-company-profile , Ci-private-wealth , Inovio-pharmaceuticals , Inovio-pharmaceuticals-stock-performance , News-ratings-for-inovio-pharmaceuticals-daily , Mirae-asset-global-investments-co , Inovio-pharmaceuticals-inc , Institutional-investors-weigh-in-on-inovio-pharmaceuticals , Royal-bank , Wealth-group

Inovio Pharmaceuticals (NASDAQ:INO) Lifted to "Hold" at StockNews.com

StockNews.com upgraded shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) from a sell rating to a hold rating in a research report released on Friday morning. Several other equities analysts also recently weighed in on INO. Royal Bank of Canada reissued a sector perform rating on shares of Inovio Pharmaceuticals in a research note on […]

Blackrock , Nova-scotia , Canada , Inovio-pharmaceuticals-stock , Inovio-pharmaceuticals , Vanguard-group-inc , Geode-capital-management , Inovio-pharmaceuticals-company-profile , News-ratings-for-inovio-pharmaceuticals-daily , Institutional-investors-weigh-in-on-inovio-pharmaceuticals , Renaissance-technologies

Short Interest in Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Declines By 5.8%

Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Get Free Report) saw a large decrease in short interest in January. As of January 15th, there was short interest totalling 22,510,000 shares, a decrease of 5.8% from the December 31st total of 23,890,000 shares. Based on an average daily volume of 3,570,000 shares, the short-interest ratio is currently 6.3 […]

Vanguard-group-inc , Nasdaq , Metlife-investment-management , Hsbc-holdings , Charles-schwab-investment-management-inc , Inovio-pharmaceuticals , Renaissance-technologies , Inovio-pharmaceuticals-inc , News-ratings-for-inovio-pharmaceuticals-daily , Inovio-pharmaceuticals-company-profile , Inovio-pharmaceuticals-stock-performance

Inovio Pharmaceuticals (NASDAQ:INO) Shares Down 6.8%

Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Get Free Report)’s share price was down 6.8% during mid-day trading on Thursday . The stock traded as low as $6.41 and last traded at $6.46. Approximately 126,013 shares changed hands during trading, a decline of 79% from the average daily volume of 599,254 shares. The stock had previously closed […]

Inovio-pharmaceuticals-price-performance , Inovio-pharmaceuticals-inc , Allspring-global-investments-holdings , Ci-private-wealth , Inovio-pharmaceuticals-company-profile , Nasdaq , Inovio-pharmaceuticals , News-ratings-for-inovio-pharmaceuticals-daily , Get-free-report , Global-investments-holdings , Point-capital-management

Inovio Pharmaceuticals (NASDAQ:INO) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) in a report released on Monday. The firm issued a hold rating on the biopharmaceutical company’s stock. Inovio Pharmaceuticals Price Performance INO stock opened at $0.38 on Monday. The business has a 50 day simple moving average of $0.41 and a 200-day simple […]

Blackrock-inc , Inovio-pharmaceuticals-company-profile , Institutional-investors-weigh-in-on-inovio-pharmaceuticals , Inovio-pharmaceuticals-price-performance , Vanguard-group-inc , Inovio-pharmaceuticals-inc , Millennium-management , Renaissance-technologies , News-ratings-for-inovio-pharmaceuticals-daily , Inovio-pharmaceuticals , Free-report

Inovio Pharmaceuticals (NASDAQ:INO) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) in a report released on Sunday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Inovio Pharmaceuticals Trading Down 5.8 % INO stock opened at $0.38 on Friday. Inovio Pharmaceuticals has a one year low of $0.32 and a one […]

Blackrock-inc , Geode-capital-management , Inovio-pharmaceuticals-inc , News-ratings-for-inovio-pharmaceuticals-daily , Inovio-pharmaceuticals-company-profile , Inovio-pharmaceuticals-trading-down , Vanguard-group-inc , Renaissance-technologies , Inovio-pharmaceuticals , Institutional-trading-of-inovio-pharmaceuticals , Free-report

Inovio Pharmaceuticals (NASDAQ:INO) Now Covered by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) in a research report released on Thursday. The firm issued a hold rating on the biopharmaceutical company’s stock. Inovio Pharmaceuticals Stock Performance Shares of INO opened at $0.51 on Thursday. The stock has a market cap of $137.47 million, a P/E ratio of […]

Beck-bode , Institutional-investors-weigh-in-on-inovio-pharmaceuticals , News-ratings-for-inovio-pharmaceuticals-daily , Allspring-global-investments-holdings , Inovio-pharmaceuticals-company-profile , Inovio-pharmaceuticals , Inovio-pharmaceuticals-inc , Inovio-pharmaceuticals-stock-performance , Capital-investment-advisors , Free-report , Get-free-report

Inovio Pharmaceuticals (NASDAQ:INO) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) in a report published on Tuesday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Inovio Pharmaceuticals Stock Performance Shares of INO opened at $0.38 on Tuesday. The stock has a 50 day simple moving average of $0.44 and a […]

Hsbc-holdings , Group-plc , Inovio-pharmaceuticals-inc , Inovio-pharmaceuticals-stock-performance , Fund-management-co , News-ratings-for-inovio-pharmaceuticals-daily , E-fund-management-co , Institutional-investors-weigh-in-on-inovio-pharmaceuticals , Inovio-pharmaceuticals , Nuveen-asset-management , Inovio-pharmaceuticals-company-profile

Inovio Pharmaceuticals (NASDAQ:INO) Earns Sell Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) in a report issued on Monday. The firm issued a sell rating on the biopharmaceutical company’s stock. Inovio Pharmaceuticals Stock Performance INO stock opened at $0.39 on Monday. The stock has a market cap of $104.55 million, a P/E ratio of -0.60 and […]

Hedge-funds-weigh-in-on-inovio-pharmaceuticals , Inovio-pharmaceuticals-stock-performance , Renaissance-technologies , Inovio-pharmaceuticals , Inovio-pharmaceuticals-inc , Inovio-pharmaceuticals-company-profile , Vanguard-group-inc , News-ratings-for-inovio-pharmaceuticals-daily , Charles-schwab-investment-management-inc , Hsbc-holdings , Metlife-investment-management